Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,342 | 405 | 97.6% |
| Grant | $100.00 | 1 | 1.3% |
| Education | $84.00 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,436 | 216 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $648.56 | 33 | $0 (2024) |
| Celgene Corporation | $585.95 | 24 | $0 (2024) |
| PFIZER INC. | $557.50 | 27 | $0 (2024) |
| Janssen Biotech, Inc. | $556.40 | 26 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $285.33 | 9 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $231.08 | 21 | $0 (2018) |
| IRONWOOD PHARMACEUTICALS, INC | $194.01 | 13 | $0 (2024) |
| Novo Nordisk Inc | $125.00 | 2 | $0 (2023) |
| Ethicon US, LLC | $122.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,672 | 82 | ABBVIE INC. ($685.76) |
| 2023 | $1,552 | 83 | ABBVIE INC. ($762.10) |
| 2022 | $926.44 | 58 | ABBVIE INC. ($530.86) |
| 2021 | $803.14 | 45 | AbbVie Inc. ($399.16) |
| 2020 | $412.90 | 22 | AbbVie Inc. ($328.37) |
| 2019 | $620.16 | 24 | Ethicon US, LLC ($122.00) |
| 2018 | $680.67 | 43 | AbbVie, Inc. ($236.75) |
| 2017 | $858.46 | 50 | AbbVie, Inc. ($393.87) |
All Payment Transactions
407 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: Immunology | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.91 | General |
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $34.18 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/23/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Immunology | ||||||
| 10/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: LIVER DISEASE | ||||||
| 10/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/26/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $29.95 | General |
| Category: Neuroscience | ||||||
| 09/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 636 | 687 | $388,800 | $65,970 |
| 2022 | 11 | 759 | 844 | $460,035 | $75,524 |
| 2021 | 12 | 737 | 819 | $385,510 | $70,033 |
| 2020 | 12 | 773 | 841 | $395,595 | $65,278 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 223 | $50,175 | $21,035 | 41.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 91 | 91 | $91,000 | $10,698 | 11.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 49 | 49 | $63,700 | $10,252 | 16.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 46 | 46 | $43,010 | $8,365 | 19.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 118 | 121 | $96,800 | $8,220 | 8.5% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 21 | 25 | $20,000 | $3,205 | 16.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $13,090 | $2,019 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 29 | $4,350 | $1,832 | 42.1% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 89 | 89 | $6,675 | $344.28 | 5.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 169 | 229 | $51,525 | $21,208 | 41.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 59 | 59 | $76,700 | $11,890 | 15.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 60 | 60 | $56,100 | $11,359 | 20.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 137 | 152 | $121,600 | $10,772 | 8.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 96 | 96 | $96,000 | $9,835 | 10.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $14,025 | $2,121 | 15.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 11 | 11 | $10,285 | $2,089 | 20.3% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 16 | 17 | $13,600 | $2,055 | 15.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $3,850 | $1,912 | 49.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 27 | $4,050 | $1,672 | 41.3% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 156 | 164 | $12,300 | $612.42 | 5.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 149 | 193 | $43,425 | $19,653 | 45.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 123 | 133 | $106,535 | $10,483 | 9.8% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 44 | 44 | $57,200 | $9,327 | 16.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 46 | 46 | $43,010 | $8,975 | 20.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 75 | 76 | $76,000 | $8,837 | 11.6% |
About Dr. Peter Margolis, MD
Dr. Peter Margolis, MD is a Gastroenterology healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659457133.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Margolis, MD has received a total of $7,526 in payments from pharmaceutical and medical device companies, with $1,672 received in 2024. These payments were reported across 407 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,342).
As a Medicare-enrolled provider, Margolis has provided services to 2,905 Medicare beneficiaries, totaling 3,191 services with total Medicare billing of $276,806. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Providence, RI
- Active Since 10/27/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1659457133
Products in Payments
- RINVOQ (Biological) $893.65
- HUMIRA (Biological) $723.78
- SKYRIZI (Biological) $718.96
- XIFAXAN (Drug) $646.63
- Humira (Biological) $619.31
- ZEPOSIA (Drug) $570.60
- STELARA (Biological) $399.54
- XELJANZ (Drug) $311.67
- Trulance (Drug) $231.08
- LINZESS (Drug) $204.51
- VIBERZI (Drug) $190.38
- LINX Reflux Management System (Device) $122.00
- Entyvio (Biological) $106.27
- GENERAL GI DILATATION (Device) $100.00
- CREON (Drug) $95.94
- TREMFYA (Drug) $95.45
- MOTEGRITY (Drug) $92.89
- GATTEX (Drug) $92.02
- INFLECTRA (Biological) $78.48
- REMICADE (Biological) $61.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Providence
Thomas Sepe, Md, MD
Gastroenterology — Payments: $383,523
Paul Akerman, Md, MD
Gastroenterology — Payments: $163,964
Sean Fine, M.d, M.D
Gastroenterology — Payments: $63,236
Dr. Alan Epstein, M.d, M.D
Gastroenterology — Payments: $59,290
Samir Shah, M.d, M.D
Gastroenterology — Payments: $45,756
Lisa Mueller, Md, MD
Gastroenterology — Payments: $22,692